Aya M. Kelly

Statistics

Publications

Citations

107

H-Index

Active since

2022

Affiliations

University of Illinois Urbana-Champaign(Current)

Aya M. Kelly is an author at University of Illinois Urbana-Champaign specializing in enzyme inhibition, antimicrobial resistance, and resistance in gram-negative bacteria.

ORCID

Publications per year

2022–2022

Publications

An Iterative Approach Guides Discovery of the FabI Inhibitor Fabimycin, a Late-Stage Antibiotic Candidate with <i>In Vivo</i> Efficacy against Drug-Resistant Gram-Negative Infections

Erica N. Parker, Brett N. Cain, Behnoush Hajian et al. · ACS Central Science · 2022 · 76 citations · Full text

Life Sciences, Medicinal Chemistry, Microbiology +17

Novel Imidazotetrazine Evades Known Resistance Mechanisms and Is Effective against Temozolomide-Resistant Brain Cancer in Cell Culture

Riley L. Svec, Sydney A. McKee, Matthew R. Berry et al. · ACS Chemical Biology · 2022 · 20 citations · Full text

Medicine, Oncology, Pharmacology +17

Target-Agnostic P-Glycoprotein Assessment Yields Strategies to Evade Efflux, Leading to a BRAF Inhibitor with Intracranial Efficacy

Aya M. Kelly, Matthew R. Berry, Sarah Z. Tasker et al. · Journal of the American Chemical Society · 2022 · 11 citations · Full text

Medicine, Oncology, Pharmacology +16

1–3 of 3